SCHEMBL3278632

SCHEMBL3278632

CC1(C)CCC(N)C(=O)NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781982 0.76 PSEN1 (0.31)
SCHEMBL23975737 0.75 BLM (0.31)
SCHEMBL14170465 0.73 CCR2 (0.35)
SCHEMBL4012275 0.66
SCHEMBL50584 0.66
SCHEMBL50585 0.66
SCHEMBL29646367 0.66
SCHEMBL20588809 0.66
SCHEMBL13483622 0.66
Hydrochloric Acid SCHEMBL2114066 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828119-B2 Deprotecting a hydroxide or amine; obtain sample, incubate with enzyme, remoe protecting group, recover amine BRISTOL MYERS SQUIBB COMPANY 2004-12-07 US claimed
EP-1348025-A2 ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES Bristol-Myers Squibb Company (US) 2003-10-01 EP claimed
US-20020123110-A1 Enzymatic deprotection of amines and hydroxides BRISTOL-MYERS SQUIBB COMPANY 2002-09-05 US claimed
WO-2002053724-A2 ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-07-11 WO claimed
US-7696328-B2 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-13 US disclosed
US-20090104670-A1 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor BRISTOL-MYERS SQUIBB COMPANY 2009-04-23 US disclosed
US-7416876-B2 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme BRISTOL-MEYERS SQUIBB COMPANY (US) 2008-08-26 US disclosed
US-7390801-B2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds ATHENA NEUROSCIENCES, INC. (US) 2008-06-24 US disclosed
US-7390801-B2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds ATHENA NEUROSCIENCES, INC. (US) 2008-06-24 US disclosed
US-20070203108-A1 Alzheimer's disease; 5-{N'-(4-thianaphthenacetyl)-L-alaninyl}-amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one THORSETT EUGENE D 2007-08-30 US disclosed
US-20070203108-A1 Alzheimer's disease; 5-{N'-(4-thianaphthenacetyl)-L-alaninyl}-amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one THORSETT EUGENE D 2007-08-30 US disclosed
US-20060275878-A1 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor BRISTOL-MYERS SQUIBB COMPANY 2006-12-07 US disclosed
US-7119188-B2 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor BRISTOL-MYERS SQUIBB COMPANY (US) 2006-10-10 US disclosed
US-20060149047-A1 N-CARBOBENZYLOXY (N-CBZ)-DEPROTECTING ENZYME AND USES THEREFOR BRISTOL-MYERS SQUIBB COMPANY 2006-07-06 US disclosed
US-6828119-B2 Deprotecting a hydroxide or amine; obtain sample, incubate with enzyme, remoe protecting group, recover amine BRISTOL MYERS SQUIBB COMPANY 2004-12-07 US disclosed
EP-1348025-A2 ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES Bristol-Myers Squibb Company (US) 2003-10-01 EP disclosed
US-20020123110-A1 Enzymatic deprotection of amines and hydroxides BRISTOL-MYERS SQUIBB COMPANY 2002-09-05 US disclosed
WO-2002053724-A2 ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-07-11 WO disclosed